Can I start HRT in my late 50s or is it too late?

Short answer: Yes — it’s usually not “too late.” People in their late 50s can start hormone therapy for menopausal symptoms or begin gender‑affirming HRT, but the decision is individualized and depends on your medical history and goals.

A few quick distinctions (tell me which you mean if you want more detail):

• Menopausal HRT (to treat hot flashes, night sweats, vaginal dryness, bone loss)
• Gender‑affirming HRT (feminizing or masculinizing)

What clinicians consider

• Benefits: relief of vasomotor symptoms, improved sleep/mood and quality of life; vaginal estrogen strongly improves local urogenital symptoms; HRT can help bone health.
• Risks: higher risk of venous thromboembolism (VTE), stroke, and (depending on formulation and duration) breast cancer and cardiovascular effects — these risks rise with age and some medical conditions.
• Timing: guidelines often note greatest net benefit when started within ~10 years of menopause or before age ~60, but older people can still gain symptom relief if risks are acceptable.
• Contraindications: active or recent hormone‑sensitive cancer, active VTE or clotting disorder, uncontrolled cardiovascular disease or severe liver disease — these need careful review.

Practical options and why (examples)

• Transdermal estradiol patches (lower VTE risk than oral estrogen): Vivelle‑Dot, Climara — good if you’re older or have VTE/cardiovascular risk.
• Oral estradiol: Estrace — effective but may have higher clotting risk than transdermal.
• Micronized progesterone (if you have a uterus and need progestogen): Prometrium — often preferred for a more favorable profile than some synthetic progestins.
• Vaginal/local estrogen for isolated pelvic/vaginal symptoms (very low systemic exposure): Vagifem (vaginal tablets), Imvexxy (estradiol inserts), Estring (ring).
• For feminizing gender‑affirming care: estradiol patches (Vivelle‑Dot) + anti‑androgen where used (spironolactone/Aldactone in the U.S.) — transdermal estradiol preferred if VTE risk is a concern.
• For masculinizing therapy: testosterone gels (AndroGel, Testim) or injections — doses and monitoring adjusted for age/health.

Monitoring and tests commonly done before/after starting

• Baseline: medical history, blood pressure, lipids, fasting glucose/HbA1c, BMI, liver tests, smoking status, and (for menopausal HRT) recent mammogram and pelvic exam as indicated.
• Ongoing: periodic blood pressure, symptom review, mammograms per screening guidelines, and labs tailored to therapy (e.g., testosterone/estradiol levels for trans care, LFTs if indicated).

Where to get help (services/clinics)

• See your primary care clinician, gynecologist, or an endocrinologist/menopause specialist for menopausal HRT.
• For gender‑affirming care: specialized clinics or community health centers — examples in the U.S.: Fenway Health (Boston), Whitman‑Walker (DC), Planned Parenthood health centers, or telehealth providers such as Plume or Folx Health (they provide counseling and prescriptions in many states). Local LGBTQ+ clinics can help locate trusted services.
• If you want a menopause specialist, look for North American Menopause Society (NAMS)‑affiliated clinicians.

Next steps

1. Tell your clinician what symptoms you want treated and your medical history (clots, stroke, heart disease, cancer, smoking).
2. Get baseline screening (mammogram if due), BP and basic labs.
3. Discuss formulation (transdermal vs oral vs vaginal), dose, and monitoring plan.
4. Reassess risks/benefits at intervals and adjust therapy.

If you tell me whether you mean menopausal HRT or gender‑affirming HRT, your main symptoms/concerns, and your health history (clotting, heart disease, cancer, smoking), I can give more specific options and monitoring suggestions.